KSE 100 :    OGDC 55.50 0.51    AHSL 24.35 -0.33    JSCL 28.17 -0.07    PTC 14.18 0.24    NBP 67.51 1.29    NIB 4.51 0.05    ANL 18.47 1.00    BAFL 11.73 0.14    FFBL 18.02 0.49    UBL 44.96 0.77    FABL 14.27 -0.09    ATRL 56.24 1.79    ICI 70.48 3.35    HUBC 17.48 0.02    ENGRO 108.40 0.70    LPCL 3.00 0.06    LUCK 36.56 0.33    MCB 126.81 4.51    FFC 73.16 0.79    WTL 2.52 0.14    AICL 52.58 0.07    AKBL 16.06 0.61    PPL 145.48 2.52    HBL 102.13 0.84    JSBL 4.98 0.28    PSO 141.37 5.03    FCSC 10.21 0.03    BOP 9.37 -0.01    PIAA 2.99 0.23    SSGC 13.25 0.00
web design guide
Provided by the web design guide.

Thursday, November 27, 2008

Intel to market personal health system

Intel Corporation has received clearance from the US Food and Drug Administration (FDA) to market its personal health system in the United States. The Intel Health Guide is a care management tool for healthcare professionals who manage patients with chronic conditions.

The Health Guide enables caregivers to provide their patients with more personalised care at home, while also engaging and empowering patients to take a more active and positive role in their own care. The company also hopes to market the product in the UK later this year or early 2009.

The Health Guide combines an in-home patient device (see photo below), as well as an online interface allowing clinicians to monitor patients and remotely manage care. The system offers interactive tools for personalised care management and integrates vital sign collection, patient reminders, multimedia educational content and feedback and communications tools such as videoconferencing and email.

The in-home patient device of the Intel Health Guide system
The in-home patient device of the Intel Health Guide system

No comments: